News

For additional media information, contact:
Arthur J. Shannon, Vice President, Investor Relations and Communications
ajshannon@perrigo.com
269-686-1709(direct)
269-673-9128 (fax)

 

Archive: 2009 | 2008 | 2007 | 2006  | 2005 | 2004 | 2003 | 2002

2010

Perrigo Receives FDA Clearance to Manufacture New Infant Formula Liquid Concentrate and Ready-to-Use Products
August 25, 2010
   See Attachment

Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma
August 19, 2010
   See Attachment  

Perrigo Confirmat Patent Challenge for Clobetasol Propionate Emulsion Foam
July 14, 2010
 See Attachment

Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 from Teva 
June 29, 2010
 See Attachment

Perrigo to Present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging and Leisure Conference 
June 25, 2010
See Attachment

Perrigo Acquires Rights to Generic Version of HalfLytely® From Novel Laboratories
May 26, 2010
  See Attachment

Perrigo to Present at the Citi Investment Research Global Health Care Conference
May 24, 2010
 See Attachment

Perrigo Acquires Exclusive Sales and Distribution Rights to Generic Version of Delsym® From Tris Pharma
May 5, 2010
See Attachment

Perrigo Closes Acquisition of Infant Formula Manufacturer PBM Holdings
May 3, 2010
See Attachment

Perrigo Reports Record Third Quarter Revenue, All-Time Record Earnings, and Raises Full Year Adjusted EPS Guidance
April 29, 2010
  See Attachment

Perrigo Company Announces Quarterly Dividend
April 28, 2010
 See Attachment

Perrigo Will Release Third Quarter Fiscal 2010 Results on April 29, 2010
April 16, 2010
 See Attachment

Perrigo is Named Authorized Generic Partner by Ferndale Laboratories and Launches Analpram HC® Cream
April 15, 2010
See Attachment

Perrigo and Graceway Settle Litigation and Name Perrigo as the Authorized Generic Distributor for Aldara®
April 13, 2010
See Attachment

Perrigo Wins Unfair Competition Case
April 8, 2010
See Attachment  

Perrigo and Partner Cobrek Announce Settlement of Luxiq® Patent Litigation
April 5, 2010
See Attachment     

Perrigo and Partner Cobrek Launch Generic Version of Evoclin® and Announce Settlement of Related Litigation
April 5, 2010
See Attachment    

Perrigo Acquires Infant Formula Manufacturer PBM Holdings fo $808 Million
March 23, 2010
See Attachment

Perrigo Announces Launch of Generic Version of Zaditor™
March 15, 2010
See Attachment 

Perrigo Announces FDA Final Approval for Ciclopirox Shampoo
February 18, 2010
See Attachment